SCHEMBL17607174

SCHEMBL17607174

O=C(Nc1ccc(CN2CCNCC2)nc1)c1ccc[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK7 Q13164 3/20 0.58
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
GFER P55789 1/20 0.47
HIF1A Q16665 1/20 0.44
EPAS1 Q99814 1/20 0.44
SCN9A Q15858 1/20 0.43
TMIGD3 P0DMS9 1/20 0.43
ADORA1 P30542 1/20 0.43
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
ACKR3 P25106 1/20 0.41
KDM1A O60341 1/20 0.41
RCOR1 Q9UKL0 1/20 0.41
CLK2 P49760 1/20 0.41
CLK3 P49761 1/20 0.41
DYRK1A Q13627 1/20 0.41
PAICS P22234 1/20 0.41
CDK2 P24941 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17607206 0.88 HIF1A (0.58) MAPK7NPC1RAB9AGFERHIF1A
SCHEMBL18083787 0.77 CHRM3 (0.52) MAPK7HIF1AEPAS1ACKR3MCHR1
SCHEMBL20265777 0.74 MAPK7 (1.00) MAPK7
SCHEMBL17607243 0.72 MAPK7 (0.47) MAPK7NPC1RAB9AGFERSCN9A
SCHEMBL17607239 0.71 TMIGD3 (0.46) MAPK7NPC1RAB9AGFERSCN9A
SCHEMBL18083686 0.71 DGAT1 (0.56) MAPK7HIF1AEPAS1MCHR1
SCHEMBL17239852 0.69 HRH3 (0.46) MAPK7HIF1AEPAS1MCHR1
SCHEMBL22085872 0.69 HIF1A (0.46) NPC1RAB9AHIF1AEPAS1
SCHEMBL3399676 0.69 HIF1A (0.47) MAPK7HIF1AEPAS1PAICSKDM5C
SCHEMBL15251315 0.68 KDM5C (0.52) MAPK7HIF1AEPAS1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194390-A1 PYRROLCARBOXAMIDE DERIVATIVES FOR THE INHBITION OF ERK5 Cancer Research Technology Ltd (GB) 2017-07-26 EP claimed
WO-2016042341-A1 PYRROLCARBOXAMIDE DERIVATIVES FOR THE INHBITION OF ERK5 CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-03-24 WO claimed